BiQ: Quick Comparison of Leading Clinical-Stage Regimens for 1L mPDAC

I hope everyone is having a great holiday season! For those of us who still like to think about biotech, even during the Holidays, here's a quick side-by-side comparison of leading clinical-stage candidates for the treatment of 1L mPDAC.

Please refer to the BiQAP Live spreadsheet on the Active Portfolio page or the iQCS for additional information.

Not a BiQ Premium member, or have a friend who may be interested? Try BiQ Premium for $50 per month, or $250 (50% off) for the first year.

Biotech iQ is 100% subscriber supported. If you find this information helpful, please spread the word. You can also follow me on X @ Biotech iQ (_Biotech_iQ).

Biotech iQ is not an investment professional, and nothing on this page or this website should be considered investment advice. Please consult with a licensed investment professional as necessary. Past performance is not indicative of future results.